There are 437 resources available
Oncogene-addicted metastatic NSCLC case presentation
Presenter: Mariana Brandão
Session: ESMO Clinical Practice Guidelines 1
Resources:
Slides
Webcast
Who should and shouldn't get surgery?
Presenter: Jonathan Spicer
Session: Managing stage III NSCLC in the era of IO
Resources:
Slides
Webcast
Perspective from the Chair
Presenter: Tony S.K. Mok
Session: Adjuvant or neoadjuvant immunotherapy or both in localised NSCLC
Resources:
Slides
Webcast
1459P - Preliminary efficacy and safety of KN046 (a bispecific anti-PD-L1/CTLA-4) in patients with metastatic non-small cell lung cancer who previously treated with immune checkpoint inhibitor(s)
Presenter: Caicun Zhou
Session: Poster session 20
1335P - Phase Ib study to evaluate the safety and tolerability of osimertinib with ipilimumab in EGFRm NSCLC
Presenter: Sonam Puri
Session: Poster session 19
1463P - IL-6 triggers chemoimmunotherapy resistance by creating immunosuppressive tumor microenvironment in non-small cell lung cancer
Presenter: Yaning Yang
Session: Poster session 20
1449P - The preliminary data from a single-arm, open-label, multicenter phase II clinical trial: KN046 combined with axitinib as first-line (1L) treatment for NSCLC
Presenter: Yuanyuan Zhao
Session: Poster session 20
1300P - Treatment and clinical outcome in recurrent/refractory locally advanced NSCLC following chemoradiotherapy and consolidative durvalumab
Presenter: Georg Evers
Session: Poster session 04
Invited Discussant LBA99 and LBA93
Presenter: Joachim Aerts
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Expanding opportunities in patients with metastatic NSCLC
Presenter: Enriqueta Felip
Session: Gilead Sciences Europe Ltd - MILLIONS OF LIVES. ONE MISSION. Exploring the potential of ADCs in multiple solid tumours
Resources:
Webcast